SUZANOBAGIMD™ - How It Works
Dr. Suzan Obagi talks about SUZANOBAGIMD
Next-generation Products that Cleanse, Protect and Renew the Skin
The SUZANOBAGIMD line is a unique line of scientifically formulated products that cleanse dirt and other impurities while defending against UV rays* and rejuvenating the skin. A 3-step process for individualized skin care is the core philosophy behind the SUZANOBAGIMD product line:
With the SUZANOBAGIMD line, a range of options can be used together or integrated with an Obagi® system or product for a completely customized skin care regimen.
Clinically studied, dermatologist-tested ingredients plus potent antioxidants provide effective treatment with a gentle touch:In a clinical study with a proprietary formulation of powerful ingredients,8,‡ significant improvements (P<.005) in skin clarity were observed only 20 minutes after use in
- Pore cleanliness
- Sebum spot/oiliness levels
- Skin scaling
- Moisture levels
Retinaldehyde is a Vitamin A precursor of retinoic acid that has been shown to improve the appearance of firmness and elasticity, and reduce the appearance of fine wrinkles and roughness.
Polyhydroxy acids (PHAs)
The humectant and moisturizing properties of the PHAs gluconolactone and lactobionic acid, as well as their exfoliating effects, help protect the skin barrier while reducing signs of photoaging such as the appearance of fine lines and roughness.
*Only Soothing Complex Broad Spectrum SPF 25 contains physical UVA and UVB protection. †Following a comprehensive sun protection program including applying a broad-spectrum sunscreen, wearing sun-protective clothing including hats and sunglasses and avoiding the sun between 10:00 am and 2:00 pm decreases the risk of certain types of skin cancer and premature aging of the skin. ‡Study results for a clinical evaluation of formulation effectiveness; N=30. Proprietary formulation is included in Foaming Cleanser, Balancing Toner, Cleansing Wipes, Acne Cleansing Wipes and Soothing Complex. Proprietary formulation is not included in Retivance® Skin Rejuvenating Complex and Intensive Daily Repair (IDR). References: 1. Grimes PE, Green BA, Wildnauer RH, Edison BL. The use of polyhydroxy acids (PHAs) in photoaged skin. Cutis. 2004;73(suppl 2):3-13. 2. Berardesca E, Distante F, Vignoli GP, Oresajo C, Green B. Alpha hydroxyacids modulate stratum corneum barrier function. Br J Dermatol. 1997;137(6):934-938. 3. Green BA, Edison BL, Sigler ML. Antiaging effects of topical lactobionic acid: results of a controlled usage study. Cosmet Dermatol. 2008;21(2):76-82. 4. Diridollou S, Vienne MP, Alibert M, et al. Ef cacy of topical 0.05% retinaldehyde in skin aging by ultrasound and rheological techniques. Dermatology. 1999;199(suppl 1):37-41. 5. Creidi P, Vienne MP, Ochonisky S, et al. Pro lometric evaluation of photodamage after topical retinaldehyde and retinoic acid treatment. J Am Acad Dermatol. 1998;39(6):960-965. 6. Creidi P, Humbert PH. Clinical use of topical retinaldehyde on photoaged skin. Dermatology. 1999;199(suppl 1):49-52. 7. Smijs TG, Pavel S. Titanium dioxide and zinc oxide nanoparticles in sunscreens: focus on their safety and effectiveness. Nanotechnol Sci Appl. 2011;4:95-112. 8. BioSpectrum, Inc. A clinical study of skin moisture, sebum, scaling for Bio-Detox on human skin. August 6-9, 2012. OMP, Inc. Data on file. 9. Fluhr JW, Vienne MP, Lauze C, Dupuy P, Gehring W, Gloor M. Tolerance pro le of retinol, retinaldehyde and retinoic acid under maximized and long-term clinical conditions. Dermatology. 1999;199(suppl 1):57-60. 10. Saurat JH, Didierjean L, Masgrau E, et al. Topical retinaldehyde on human skin: biologic effects and tolerance. J Invest Dermatol. 1994;103(6):770-774. 11. Grimes PE, Green BA, Wildnauer RH, Edison BL. The use of polyhydroxy acids (PHAs) in photoaged skin. Cutis. 2004;73(suppl 2):3-13. 12. Berardesca E, Distante F, Vignoli GP, Oresajo C, Green B. Alpha hydroxyacids modulate stratum corneum barrier function. Br J Dermatol. 1997;137(6):934-938. 13. Green B, Tseng C, Wildnauer R, Herndon Jr JH, Rizer RL. Safety and efficacy of a gluconolactone (poly hydroxyacid) containing regimen on sensitive skin and photodamage following controlled consumer use. Poster. 14. Green BA, Edison BL, Sigler ML. Antiaging effects of topical lactobionic acid: results of a controlled usage study. Cosmet Dermatol. 2008;21(2):76-82. 15. Green BA, Yu RJ, Van Scott EJ. Clinical and cosmeceutical uses of hydroxyacids. Clin Dermatol. 2009;27(5):495-501.